Navigate Through Our Insights

Client Alert June 18, 2024

Annual ERISA Litigation Review and Outlook – 2024

Gibson Dunn's ERISA litigation update summarizes key legal opinions and developments during the past year to assist plan sponsors and administrators navigating the rapidly changing ERISA litigation landscape.  

Client Alert March 21, 2023

Annual ERISA Litigation Outlook and 2022 Review

Our lawyers discuss the year in Employee Retirement Income Security Act litigation, as a way to help plan sponsors and administrators navigate the ever-evolving ERISA landscape.

Client Alert September 7, 2022

D.C. Circuit Foreign Sovereign Immunities Act Enforcement Update (September 2022)

Gibson Dunn’s D.C. Circuit Foreign Sovereign Immunities Act Enforcement Update summarizes recent decisions within the D.C. Circuit that are relevant to the enforcement of judgments and arbitral awards against foreign states.

Client Alert February 22, 2022

2021 ERISA Litigation Update

This year’s Annual ERISA Litigation Update summarizes key legal opinions and developments to assist plan sponsors and administrators navigating the rapidly changing ERISA litigation landscape.

Firm News November 4, 2021

Gibson Dunn Promotes 27 Lawyers to Partnership

Gibson, Dunn & Crutcher LLP is pleased to announce that the firm has elected 27 new partners, effective January 1, 2022. 

Client Alert February 11, 2021

2020 Year-End ERISA Disputes Update

With the emergence of COVID-19, 2020 was a year of significant and unprecedented change in daily life and the economy. In particular, 2020 was a busy year for Employee Retirement Income Security Act (“ERISA”) lawsuits—across industries—implicating employers’ retirement and healthcare plans.

Client Alert February 2, 2021

Department of Health and Human Services Delays Effective Date of Final Rule Limiting Retrospective Manufacturer Rebates on Medicare Part D Prescription Drug Prices

On January 29, 2021, Pharmaceutical Care Management Association, a national trade association representing pharmacy benefit managers, secured a one-year stay in a challenge to a new regulation issued by the Department of Human Health and Services Office of Inspector General that sought to prohibit PBMs and plan sponsors from accepting retrospective manufacturer rebates under Medicare Part D plans.

Publications January 7, 2021

Invalid appointments and the restoration of DACA

San Francisco partner Ethan Dettmer and Washington, D.C. associates Suria Bahadue and Matthew Rozen are the authors of “Invalid appointments and …